COVID-19 vs. The Pot Industry: A Cannabis Terpene Formulation, Inclusion in Stimulus Relief Bill, and…Federal Equality?

In the early months of 2020, Covid-19 fell upon the US, having an unforeseen impact on the marijuana industry. Not only has pot been solidified as a staple of American life, but through the difficulties braved by companies in the face of rampant business closures, dispensaries’ delivery services were actually able to help Big Marijuana emerge as a dark horse in the race to stay alive during the massive corporate upheaval which the government is still working to repair, distributing trillions the effort. Unfortunately, cannabis workers have as of yet not been able to receive any of coronavirus relief funds, but for the fact that marijuana is still considered federally illegal in the United States. But could weed’s essential status and involvement in a possible COVID-19 prevention formula be an impetus to federal equality for the marijuana industry?

Truly it is no wonder consumers were stocking up pot once the pandemic hit. Easing symptoms of depression, PTSD, anxiety, pain, nausea, and headaches are just a few of the many health benefits from whatever strain it is they are partaking in. On the horizon are COVID-19 prevention formulations; they is purported to be coming our way soon, and their components were under our “noses” all along.

As published in the Journal of Medicinal Chemistry, “findings suggest that specific abietane-type diterpenoids and ligioids exhibit strong anti-SARS-CoV effects”

This means, in layman’s terms, studies show particular terpenes act as a strong preventative against the effects SARS-CoV-2, which is 79% similar genetically to COVID-19.

And again, for those of us who were uncertain about what terpenes are to begin with, and what makes them so special, Eybna.com breaks it down pretty well:

“Terpenes are organic aromatic molecules that contribute to plants’ odor. They are found in Cannabis plants and many other plant species. Each Cannabis strain consists of its own unique terpene profile which creates a distinguishable effect and smell. In total, there are over 130 terpenes that have been found in cannabis.”

Following up on this new discovery, Professor Dedi Meiri from the Israel Institute of Technology and CannaSoul Chairman said in an interview with the Medical Cannabis Network, “Our lab has been approved to operate as a corona lab, and in doing so, we are promoting two studies based on existing cannabis studies.”

This exciting new information has spurned rumblings of a resurgence of the marijuana industry on Wall Street, where investors had been less than confident as of late in regard to the economic future of medical marijuana, even with its success in the delivery sector.

As it is included under the HEROES Act, if passed, the SAFE Banking Act, a bill which makes it so that marijuana businesses can utilize banking services as other companies are allowed to, will also pass. A separate bill which was filed in late April, the Emergency Cannabis Small Business Health & Safety Act, would make eligible for cannabis workers some much-needed financial relief due to the unforeseen circumstances created by the onset of the coronavirus. Over the events of this year thus far, federal equality surely must be waiting in the wings.